Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)
Agios Pharmaceuticals (AGIO) posted Divestments of $1.8 billion for Q1 2021, up 395704.4% on a QoQ basis from -$455000.0 in Q4 2020, and up 695080.69% year-over-year from N/an in Q1 2020.
Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021) Analysis & Trends
Agios Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $1.8 billion for Q1 2021.
- Quarterly Divestments rose 695080.69% year-over-year to $1.8 billion in Q1 2021, while the trailing twelve-month figure through Mar 2022 was -$455000.0 (down 100.03% YoY) and the FY2024 annual result came in at $200.0 million, changed N/A from the prior year.
- Divestments was $1.8 billion for Q1 2021 at Agios Pharmaceuticals, up from -$455000.0 in the prior quarter.
- Across five years, Divestments topped out at $1.8 billion in Q1 2021 and bottomed at -$455000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.80 Bn |
| Dec 31, 2020 | -455,000.00 |
| Jun 30, 2020 | -89,000.00 |
| Mar 31, 2020 | -259,000.00 |